Clin2
NCT07072910Possibly a fitRecruiting

Cabergoline for migraine prevention

Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests if a once-weekly medication called cabergoline can reduce how often you get migraine headaches. It is for adults who have between 4 and 14 migraine days per month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with episodic migraine (between 4 and 14 migraine days per month for the last 3 months).
  • You have not changed your migraine prevention medications in the last 3 months.
  • You do not have chronic migraine (15 or more headache days per month) or other frequent headache types.
  • You do not have a history of heart valve disease, lung, or abdominal disorders.
  • You will use reliable birth control if you or your partner could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07071506Recruiting
New tools to track migraine prevention

This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.

Aarhus C, Denmark
NCT07646613Recruiting· Phase 2
Testing an inhaled migraine medicine for quick relief

This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.

Walnut Creek, California
NCT07633067Not yet recruiting
Middle Meningeal Artery Embolization for Frequent Migraines

This trial tests a minimally invasive procedure that blocks a blood vessel in the brain to reduce migraine attacks. It may help people who have frequent migraines and haven't found relief with standard migraine medications.

NCT06893874Recruiting
Comparing migraine preventives chosen by a computer

This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.

Trondheim
NCT06968429Not yet recruiting
NBP soft capsules for preventing migraine attacks in adults

This trial tests if oral NBP soft capsules can prevent migraine attacks in adults. It compares the drug against a placebo to see if it reduces how often migraines occur.

NCT06808230Recruiting
Cocoa extract for migraine prevention study

This trial tests whether taking cocoa extract daily can help prevent migraine attacks in people with 4-14 migraines per month. You'll use a phone app to track your headaches and take either cocoa extract or a placebo.

Boston, Massachusetts

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.